因欠费被暂停III期试验,康乐卫士困境何时解?

21世纪经济报道
Jan 18

21世纪经济报道记者季媛媛   近日,康乐卫士发布公告称,公司收到山西省、江苏省两省疾控中心发来的函件:由于临床试验经费短缺,无法继续开展后续妇科访视工作,两省决定暂停其三价及九价HPV疫苗女性适应证的III期临床试验。   临床研究经费的拖欠让山西省疾控中心与江苏省疾控中心不得不向康乐卫士发出最后通牒,而这家自诩为“北交所人用疫苗第一股”的公司货币资金仅剩百万元,且至今尚未实现任何产品的商业化。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10